Cho Sung-Woo, Han Sang Y, Song Yoonjae, Kim Jeong-Whun, Kim Hyun J, Kim Dong-Young, Rhee Chae-Seo, Bae Yun J, Kim Ji-Hoon, Wu Hong-Gyun, Bang Jae S, Won Tae-Bin
Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
J Neurol Surg B Skull Base. 2021 Jan 14;83(Suppl 2):e15-e23. doi: 10.1055/s-0040-1722669. eCollection 2022 Jun.
Skull base osteoradionecrosis (SB-ORN) is a serious, potentially lethal complication of radiation therapy. We aimed to review the clinical characteristics and outcomes of SB-ORN according to the extent of treatment. Retrospective analysis design was used for this study. The study was conducted in two tertiary care hospitals. Patients included who had been clinically diagnosed with SB-ORN from January 2006 to 2017. Clinical characteristics, including demographics, predisposing factors, presenting symptoms, radiological findings, treatment modalities, and treatment outcomes, were reviewed. Treatment was classified into conservative and aggressive types. Aggressive treatment included radical surgical removal of soft tissue and bony sequestrum with the placement of vascularized tissue. Treatment outcome was analyzed in terms of clinical control, survival, and carotid artery blow out. Fifteen patients (11 males and 4 females) were identified during the study period. Eight patients were managed conservatively, whereas seven patients were managed with aggressive treatment. The 2-year survival was 75% in the aggressive treatment group and 15% in the conservative group (log-rank, = 0.049). The estimated 2-year blow out free rate was 46.7% for the conservative group and 100% for the aggressive group (log-rank, = 0.100). In patients with SB-ORN, aggressive management, including surgical removal of sequestrum and coverage with a pedicled flap, is associated with increased survival.
颅底放射性骨坏死(SB-ORN)是放射治疗一种严重的、潜在致命的并发症。我们旨在根据治疗范围回顾SB-ORN的临床特征和治疗结果。
本研究采用回顾性分析设计。
该研究在两家三级医疗中心进行。
纳入2006年1月至2017年临床诊断为SB-ORN的患者。
回顾临床特征,包括人口统计学、易感因素、症状表现、影像学表现、治疗方式和治疗结果。治疗分为保守治疗和积极治疗。积极治疗包括根治性手术切除软组织和骨坏死组织并植入带血管组织。从临床控制、生存和颈动脉破裂方面分析治疗结果。
研究期间共确定15例患者(11例男性,4例女性)。8例患者接受保守治疗,7例患者接受积极治疗。积极治疗组2年生存率为75%,保守治疗组为15%(对数秩检验,P = 0.049)。保守治疗组估计2年无破裂率为46.7%,积极治疗组为100%(对数秩检验,P = 0.100)。
在SB-ORN患者中,积极治疗,包括手术切除坏死组织并用带蒂皮瓣覆盖,与生存率提高相关。